
Our team of seasoned professionals has extensive experience in obesity research, enabling us to provide insights and tailored solutions that enhance study outcomes, ensuring your projects are in capable hands.
We maintain rigorous quality control throughout our processes, adhering to GLP principles to guarantee reliability and reproducibility in every study, aligning with global pharmaceutical expectations.
KCI Biotech offers flexible minimum order quantities (MOQ) to meet varying client needs, ensuring that both small-scale and large-scale projects are accommodated without compromising on quality or timelines.
With our one-stop CRO services, we cover all aspects of obesity-related research, from preclinical trials to toxicology, facilitating seamless project execution and stronger collaboration with clients.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china